Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,752
Total Claims
$378K
Drug Cost
492
Beneficiaries
$768
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-46%
Cost per patient vs peers
$768 vs $1,411 avg
-6%
Brand preference vs peers
10.0% vs 10.6% avg
Brand vs Generic
Brand: 1,069 claims · $226K
Generic: 9,617 claims · $149K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 53 | $33K |
| Insulin Nph Human Isophane | 70 | $20K |
| Insulin Nph Hum/Reg Insulin Hm | 65 | $20K |
| Levothyroxine Sodium | 773 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 37 | $17K |
| Empaglifloz/Linaglip/Metformin | 22 | $13K |
| Levothyroxine Sodium | 109 | $12K |
| Rivaroxaban | 19 | $10K |
| Bimatoprost | 36 | $9,738 |
| Losartan Potassium | 408 | $9,172 |
| Metoprolol Succinate | 328 | $7,137 |
| Gabapentin | 11 | $6,741 |
| Budesonide/Formoterol Fumarate | 12 | $5,739 |
| Atorvastatin Calcium | 356 | $5,292 |
| Insulin Glargine,hum.Rec.Anlog | 12 | $5,252 |
Prescribing Profile
Patient Profile
77
Avg Age
62%
Female
2.04
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data